West Total Liab vs Other Current Assets Analysis

WST Stock

USD 364.19 1.40 0.38%

West Pharmaceutical financial indicator trend analysis is more than just analyzing West Pharmaceutical current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether West Pharmaceutical is a good investment. Please check the relationship between West Pharmaceutical Total Liab and its Other Current Assets accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Total Liab vs Other Current Assets

Total Liab vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of West Pharmaceutical Total Liab account and Other Current Assets. At this time, the significance of the direction appears to have strong relationship.

The correlation between West Pharmaceutical's Total Liab and Other Current Assets is 0.73. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of West Pharmaceutical Services, assuming nothing else is changed. The correlation between historical values of West Pharmaceutical's Total Liab and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of West Pharmaceutical Services are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Total Liab i.e., West Pharmaceutical's Total Liab and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.73

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most indicators from West Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into West Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, West Pharmaceutical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 30.72 in 2024, whereas Enterprise Value is likely to drop slightly above 252.4 M in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	2.8B	2.9B	2.9B	3.1B
Depreciation And Amortization	126.1M	120.6M	137.3M	144.2M

Total Revenue Depreciation And Amortization

West Pharmaceutical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock
Total Assets		0.33	0.9	0.98	0.98	0.98	-0.87	0.97	0.97	0.98	0.48	0.97	0.98	0.67	0.12	0.99	0.91	-0.7	0.76	0.99	0.58	-0.35	0.98	0.94	0.54	0.54
Short Long Term Debt Total	0.33		0.21	0.31	0.17	0.29	0.09	0.13	0.2	0.4	0.24	0.21	0.23	0.49	0.93	0.27	0.24	0.03	0.65	0.23	-0.02	0.73	0.3	0.14	0.3	0.29
Other Current Liab	0.9	0.21		0.91	0.91	0.85	-0.9	0.89	0.94	0.85	0.6	0.94	0.92	0.58	-0.02	0.91	0.81	-0.58	0.65	0.93	0.36	-0.43	0.92	0.84	0.53	0.53
Total Current Liabilities	0.98	0.31	0.91		0.96	0.96	-0.86	0.96	0.95	0.96	0.5	0.95	0.96	0.65	0.08	0.98	0.92	-0.72	0.76	0.97	0.64	-0.33	0.98	0.93	0.49	0.5
Total Stockholder Equity	0.98	0.17	0.91	0.96		0.97	-0.93	0.99	0.98	0.96	0.44	0.98	0.99	0.63	-0.04	0.99	0.91	-0.72	0.66	0.99	0.58	-0.5	0.97	0.96	0.54	0.55
Property Plant And Equipment Net	0.98	0.29	0.85	0.96	0.97		-0.83	0.97	0.93	0.99	0.32	0.93	0.96	0.71	0.1	0.98	0.91	-0.71	0.68	0.96	0.65	-0.35	0.96	0.93	0.58	0.58
Net Debt	-0.87	0.09	-0.9	-0.86	-0.93	-0.83		-0.93	-0.95	-0.79	-0.48	-0.95	-0.92	-0.44	0.32	-0.9	-0.79	0.69	-0.5	-0.93	-0.46	0.71	-0.87	-0.89	-0.47	-0.48
Retained Earnings	0.97	0.13	0.89	0.96	0.99	0.97	-0.93		0.97	0.94	0.39	0.97	0.97	0.56	-0.09	0.98	0.93	-0.81	0.66	0.98	0.64	-0.51	0.94	0.98	0.46	0.47
Cash	0.97	0.2	0.94	0.95	0.98	0.93	-0.95	0.97		0.92	0.53	1.0	0.98	0.57	-0.03	0.98	0.88	-0.71	0.71	0.99	0.5	-0.48	0.96	0.94	0.51	0.52
Non Current Assets Total	0.98	0.4	0.85	0.96	0.96	0.99	-0.79	0.94	0.92		0.38	0.92	0.95	0.76	0.22	0.97	0.9	-0.64	0.74	0.95	0.59	-0.25	0.97	0.9	0.59	0.6
Non Currrent Assets Other	0.48	0.24	0.6	0.5	0.44	0.32	-0.48	0.39	0.53	0.38		0.53	0.52	0.29	0.15	0.48	0.43	-0.11	0.54	0.52	0.0	-0.1	0.51	0.43	0.12	0.13
Cash And Short Term Investments	0.97	0.21	0.94	0.95	0.98	0.93	-0.95	0.97	1.0	0.92	0.53		0.98	0.56	-0.02	0.98	0.88	-0.71	0.71	0.99	0.49	-0.47	0.96	0.94	0.51	0.51
Net Receivables	0.98	0.23	0.92	0.96	0.99	0.96	-0.92	0.97	0.98	0.95	0.52	0.98		0.67	0.03	0.99	0.9	-0.66	0.71	0.99	0.52	-0.45	0.98	0.93	0.55	0.56
Common Stock Shares Outstanding	0.67	0.49	0.58	0.65	0.63	0.71	-0.44	0.56	0.57	0.76	0.29	0.56	0.67		0.43	0.67	0.57	-0.06	0.42	0.62	0.28	0.02	0.72	0.48	0.75	0.76
Non Current Liabilities Total	0.12	0.93	-0.02	0.08	-0.04	0.1	0.32	-0.09	-0.03	0.22	0.15	-0.02	0.03	0.43		0.07	0.03	0.26	0.48	0.02	-0.21	0.84	0.1	-0.09	0.17	0.16
Inventory	0.99	0.27	0.91	0.98	0.99	0.98	-0.9	0.98	0.98	0.97	0.48	0.98	0.99	0.67	0.07		0.91	-0.7	0.72	0.99	0.57	-0.4	0.98	0.95	0.55	0.55
Other Current Assets	0.91	0.24	0.81	0.92	0.91	0.91	-0.79	0.93	0.88	0.9	0.43	0.88	0.9	0.57	0.03	0.91		-0.81	0.73	0.91	0.67	-0.34	0.87	0.95	0.32	0.33
Other Stockholder Equity	-0.7	0.03	-0.58	-0.72	-0.72	-0.71	0.69	-0.81	-0.71	-0.64	-0.11	-0.71	-0.66	-0.06	0.26	-0.7	-0.81		-0.57	-0.71	-0.73	0.45	-0.62	-0.85	0.02	0.01
Total Liab	0.76	0.65	0.65	0.76	0.66	0.68	-0.5	0.66	0.71	0.74	0.54	0.71	0.71	0.42	0.48	0.72	0.73	-0.57		0.73	0.31	0.13	0.72	0.67	0.15	0.16
Total Current Assets	0.99	0.23	0.93	0.97	0.99	0.96	-0.93	0.98	0.99	0.95	0.52	0.99	0.99	0.62	0.02	0.99	0.91	-0.71	0.73		0.53	-0.44	0.97	0.95	0.52	0.53
Short Term Debt	0.58	-0.02	0.36	0.64	0.58	0.65	-0.46	0.64	0.5	0.59	0.0	0.49	0.52	0.28	-0.21	0.57	0.67	-0.73	0.31	0.53		-0.29	0.55	0.68	0.12	0.13
Intangible Assets	-0.35	0.73	-0.43	-0.33	-0.5	-0.35	0.71	-0.51	-0.48	-0.25	-0.1	-0.47	-0.45	0.02	0.84	-0.4	-0.34	0.45	0.13	-0.44	-0.29		-0.37	-0.49	-0.16	-0.16
Accounts Payable	0.98	0.3	0.92	0.98	0.97	0.96	-0.87	0.94	0.96	0.97	0.51	0.96	0.98	0.72	0.1	0.98	0.87	-0.62	0.72	0.97	0.55	-0.37		0.9	0.59	0.6
Property Plant And Equipment Gross	0.94	0.14	0.84	0.93	0.96	0.93	-0.89	0.98	0.94	0.9	0.43	0.94	0.93	0.48	-0.09	0.95	0.95	-0.85	0.67	0.95	0.68	-0.49	0.9		0.37	0.38
Common Stock Total Equity	0.54	0.3	0.53	0.49	0.54	0.58	-0.47	0.46	0.51	0.59	0.12	0.51	0.55	0.75	0.17	0.55	0.32	0.02	0.15	0.52	0.12	-0.16	0.59	0.37		1.0
Common Stock	0.54	0.29	0.53	0.5	0.55	0.58	-0.48	0.47	0.52	0.6	0.13	0.51	0.56	0.76	0.16	0.55	0.33	0.01	0.16	0.53	0.13	-0.16	0.6	0.38	1.0

Click cells to compare fundamentals

West Pharmaceutical Account Relationship Matchups

West Pharmaceutical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.3B	2.8B	3.3B	3.6B	3.8B	4.0B
Short Long Term Debt Total	329.3M	325.7M	325.3M	317.9M	309M	227.6M
Other Current Liab	145.4M	226.9M	259.7M	228.1M	236M	247.8M
Total Current Liabilities	341.6M	503.4M	594.1M	519M	671.8M	705.4M
Total Stockholder Equity	1.6B	1.9B	2.3B	2.7B	2.9B	3.0B
Property Plant And Equipment Net	909.4M	1.0B	1.1B	1.3B	1.5B	1.6B
Net Debt	(109.8M)	(289.8M)	(437.3M)	(576.4M)	(544.9M)	(517.7M)
Retained Earnings	1.5B	1.8B	2.5B	3.0B	3.5B	3.7B
Cash	439.1M	615.5M	762.6M	894.3M	853.9M	896.6M
Non Current Assets Total	1.3B	1.4B	1.6B	1.7B	1.9B	2.0B
Non Currrent Assets Other	20.5M	29M	36.3M	55.9M	38.4M	32.0M
Cash And Short Term Investments	439.1M	615.5M	762.6M	894.3M	853.9M	896.6M
Net Receivables	319.3M	385.3M	489M	507.4M	512M	537.6M
Liabilities And Stockholders Equity	2.3B	2.8B	3.3B	3.6B	3.8B	4.0B
Non Current Liabilities Total	426.6M	435.9M	384.3M	412.9M	276.7M	307.8M
Inventory	235.7M	321.3M	378.4M	414.8M	434.7M	456.4M
Other Current Assets	64.6M	51.6M	112M	103M	135.8M	142.6M
Other Stockholder Equity	154.6M	99.6M	19.5M	(138.7M)	(517.4M)	(491.5M)
Total Liab	768.2M	939.3M	978.4M	931.9M	948.5M	995.9M
Total Current Assets	1.1B	1.4B	1.7B	1.9B	1.9B	2.0B
Short Term Debt	11.9M	12.4M	53.5M	18.2M	151.7M	159.3M
Intangible Assets	29.8M	30.5M	23M	18.4M	15.1M	14.3M
Accounts Payable	156.8M	213.1M	232.2M	215.4M	242.4M	254.5M
Property Plant And Equipment Gross	909.4M	1.0B	2.2B	2.4B	2.8B	3.0B
Accumulated Other Comprehensive Income	(149.6M)	(110.6M)	(159.6M)	(183M)	(143.8M)	(151.0M)
Other Liab	109.2M	117M	112.5M	113.2M	130.2M	107.9M
Other Assets	43M	52.3M	104.4M	104M	93.6M	47.0M
Long Term Debt	255M	252.9M	208.8M	206.7M	72.8M	69.2M
Good Will	107.8M	111.1M	109.9M	107.3M	108.5M	103.1M
Treasury Stock	(118.1M)	(167.7M)	(229.5M)	(370.9M)	(333.8M)	(317.1M)
Property Plant Equipment	839.3M	943.2M	1.1B	1.2B	1.3B	1.4B
Current Deferred Revenue	27.5M	51M	48.7M	57.3M	41.7M	38.2M
Net Tangible Assets	1.4B	1.7B	2.1B	2.6B	2.9B	3.1B
Retained Earnings Total Equity	1.5B	1.8B	2.5B	3.0B	3.4B	3.6B
Long Term Debt Total	255M	252.9M	208.8M	206.7M	186.0M	209.4M
Capital Surpluse	272.7M	267.3M	249M	232.2M	267.0M	223.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
BAC	Bank of America
CRM	Salesforce

When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:

How To Invest In West

Details

Is West Stock a good investment?

Details

What is West Pharmaceutical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for West Stock analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.

	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Valuation Check real value of public entities based on technical and fundamental data
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.16)

Dividend Share

0.78

Earnings Share

7.57

Revenue Per Share

39.549

Quarterly Revenue Growth

(0.03)

The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

West Total Liab vs Other Current Assets Analysis

Total Liab vs Other Current Assets

Total Liab vs Other Current Assets Correlation Analysis

Correlation Coefficient

Total Liab

Other Current Assets

West Pharmaceutical fundamental ratios Correlations

West Pharmaceutical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

West Pharmaceutical fundamental ratios Accounts

Also Currently Popular

Complementary Tools for West Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Inventory	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Net Receivables	+ 0.99	Total Stockholder Equity

Cash And Short Term Investments	- 0.95	Net Debt
Cash	- 0.95	Net Debt
Total Current Assets	- 0.93	Net Debt
Retained Earnings	- 0.93	Net Debt
Net Debt	- 0.93	Total Stockholder Equity
Net Receivables	- 0.92	Net Debt